Your testosterone came back at 400 ng/dL last month. This month you drew at a different time, and suddenly it is 1100 ng/dL. Same dose, same ester, same lab — the only difference was 48 hours. If this sounds familiar, you are not alone. Roughly 70% of the "high testosterone" results we see on TRT are drawn too close to the last injection, capturing a mid-peak surge rather than the true trough your doctor needs to see.
Timing a TRT blood draw is not complicated once you understand how esters work — but most patients never get clear instructions. Your doctor says "test at trough," and you are left guessing what that means for your specific protocol. The answer changes depending on whether you inject propionate, enanthate, cypionate, undecanoate, or sustanon. And getting it wrong has real consequences: dose reductions you do not need, labs that look wildly inconsistent, and clinical decisions based on the wrong number.
Why Timing Matters: Esters, Half-Lives, and the Trough Problem
Injectable testosterone is attached to an ester — a fatty acid chain that determines how quickly the hormone is released into your bloodstream after injection. Think of the ester as a slow-release mechanism. Testosterone without an ester (suspension) hits your system within hours and clears just as fast. Attach a propionate ester, and the release window stretches to a couple of days. Attach undecanoate, and it stretches to weeks.
The rate of release is described by two numbers: the time to peak concentration (when testosterone levels are highest after an injection) and the terminal half-life (how long it takes for the concentration to drop by half). Every ester has a different profile, and every ester produces a different peak-to-trough ratio at steady state.
Steady state is the condition where your serum levels have stabilized after 4-5 half-lives on a consistent dosing schedule, and that is where the "trough" concept comes in. The trough is the lowest point between injections — the moment just before your next dose, when serum concentration is at its minimum. In clinical TRT monitoring, the trough is the standard measurement point because it represents the lowest testosterone level your body experiences on your current protocol.
The problem is that most patients do not actually draw at true trough. They draw when it is convenient — a Wednesday morning because that is when the lab is open — regardless of when their last injection was. If you inject enanthate on Monday and draw on Thursday (day 3), you are still near your peak, not your trough. Your result might read 900 ng/dL, leading your doctor to say your levels are adequate or even high — when in reality your true trough at day 5 is 400 ng/dL.
⏰Testosterone levels should be measured at the midpoint between injections, or at the end of the dosing interval (trough level) for accurate assessment of therapeutic adequacy.
— Endocrine Society Clinical Practice Guidelines, 2018
The clinical consequence is significant. If your dose gets reduced based on a mid-peak reading, your actual trough levels drop even further, potentially below the therapeutic threshold. Conversely, a reading taken too late or inconsistently can lead to unnecessary dose increases that push your peak levels into supraphysiological ranges. Neither outcome is ideal.
Ester Half-Life Reference Table
Before we get into specific draw windows, here is the full pharmacokinetic picture for each common testosterone ester. These values are based on published data and clinical pharmacokinetic studies:
Testosterone Ester Pharmacokinetics
| Marker | Peak (approx.) | True Trough |
|---|---|---|
| Propionate | 14-20 hours post-injection | 48 hours (day 2) |
| Enanthate | 24-48 hours post-injection | 84-96 hours (day 3.5-4) |
| Cypionate | 24-72 hours post-injection | 96-120 hours (day 4-5) |
| Undecanoate | 1-2 weeks post-injection | 10-12 weeks (just before next dose) |
| Sustanon 250 | Variable (multi-ester) | Unreliable — see notes below |
A few important nuances. Enanthate and cypionate are often treated as interchangeable in clinical practice, but they are not. Cypionate has a slightly longer half-life (8-10 days versus enanthate's 4.5-7 days), which shifts the optimal draw window by roughly a full day. If your doctor switches you from one to the other, your draw window needs to shift accordingly.
Undecanoate is a completely different beast. Its absorption profile is biphasic — an initial peak around 1-2 weeks after injection, followed by a sustained plateau that gradually declines over months. The trough is technically just before your next injection, which for most protocols is every 10-14 weeks. Testing earlier than 10 weeks post-injection will almost always show levels well within range and does not give useful information about whether your dosing interval is appropriate.
Sustanon Warning
The "True Trough" Problem
The phrase "test at trough" is standard medical advice, but it is rarely accompanied by the mathematical reasoning behind it. To understand why timing matters, you need to understand the peak-to-trough ratio of your ester at steady state.
For enanthate injected weekly, the peak-to-trough ratio is approximately 1.8:1. This means that at your peak (24-48 hours post-injection), your serum testosterone is roughly 80% higher than at your trough (day 7). If you inject 100 mg of testosterone enanthate once per week, your trough might be 550 ng/dL and your peak around 990 ng/dL. The difference between those two numbers is enough to change a clinical decision.
For cypionate injected weekly, the ratio is slightly lower — approximately 1.5:1 — because the longer half-life produces a flatter curve. But for propionate injected every other day, the ratio is much tighter, around 1.2:1, because the short half-life means you never experience large swings.
The critical point is this: drawing at the wrong point in your injection cycle does not produce a "close enough" number. It produces a fundamentally different measurement that cannot be compared to previous results drawn at a different point in the cycle without understanding the pharmacokinetic correction factor. Two results drawn at different times are measuring different physiological states, and treating them as comparable leads to bad clinical decisions.
Here is what this looks like in practice. A patient injects 150 mg of testosterone cypionate every five days. He draws on day 2 after his injection (near peak) and gets a result of 1,200 ng/dL. His doctor sees this and reduces his dose to 100 mg. He continues injecting every five days, draws on day 5 (true trough) at the new dose, and gets 380 ng/dL. Both results are "accurate" — they just measure different points in the pharmacokinetic curve. The dose reduction was based on a misunderstanding of timing.
💡Roughly one in three TRT patients we analyze has inconsistent draw timing between consecutive labs. Their testosterone values bounce between 400 and 1,100 ng/dL — not because their levels changed, but because they drew at different points in the injection cycle.
— GearCheck Analysis of 500+ TRT Patients
Per-Ester Draw Windows: Exact Protocols
Here are the precise draw windows for each ester. These assume you are at steady state (4-5 half-lives into a consistent protocol) and you have been injecting on a regular schedule without skipping doses. If you recently changed your dose or your injection frequency, wait at least two weeks before drawing for a reliable trough reading.
Testosterone Propionate
Draw at: 48 hours post-injection (day 2). Propionate has the shortest half-life of the common injectable esters, approximately 19 hours. With every-other-day or daily injection protocols, steady state is reached within 3-4 days. The peak occurs 14-20 hours post-injection, and by 48 hours the level has dropped to trough.
For twice-weekly propionate (Monday morning and Thursday evening), draw on Friday morning — this is roughly 36 hours after your Thursday injection and gives you a near-trough reading. Avoid drawing within 24 hours of any injection, as you will still be near peak.
Key point: Propionate's short half-life means relatively small variations in draw time produce proportionally larger differences in serum levels. Be as precise as possible. A six-hour difference can change your result by 15-20%.
Testosterone Enanthate
Draw at: 84-96 hours post-injection (day 3.5-4). Enanthate has a half-life of approximately 4.5-7 days, with wide interindividual variation. For a once-weekly injection schedule (e.g., Monday morning), the optimal draw window is Thursday evening or Friday morning.
Many clinicians recommend drawing at the midpoint of the injection interval rather than at the very end, because the terminal elimination phase of enanthate is relatively flat. Drawing at day 3.5 produces a result that is very close to the average weekly concentration, which correlates better with clinical response than the absolute trough.
For twice-weekly enanthate (every 3.5 days, e.g., Monday morning and Thursday evening), draw on Thursday morning just before your injection — this is the true trough for that injection interval. Consistency matters more than the absolute day: if you always draw on Thursday morning, your results will be comparable even if they are not at the mathematical trough.
Testosterone Cypionate
Draw at: 96-120 hours post-injection (day 4-5). Cypionate's half-life (8-10 days) is slightly longer than enanthate's, producing a flatter pharmacokinetic curve. For a once-weekly injection, draw on day 5 or 6 post-injection, not earlier. The peak extends to 72 hours for some individuals, so drawing before day 4 risks capturing a near-peak value.
The longer half-life means that a ±12 hour variation in draw time produces a smaller change in serum levels compared to shorter esters. This makes cypionate slightly more forgiving for patients who cannot draw at exactly the same time every visit. However, weekly injections still produce meaningful swings — the peak-to-trough ratio is approximately 1.5:1.
Clinical note: Some patients on cypionate report feeling a difference between day 5 and day 7 levels, despite the relatively flat curve. If you are on a 7-day protocol and feel symptomatic toward the end of the week, consider testing at day 6 and day 7 to see how much your levels actually drop. A switch to every-5-day dosing (same weekly dose, smaller per-injection volume) often resolves the issue.
Testosterone Undecanoate
Draw at: just before your next injection. Undecanoate is unique among testosterone esters because its absorption is biphasic and its duration is measured in months, not days. After injection, there is an initial peak at 1-2 weeks, a gradual decline, and then a sustained plateau that lasts 8-12 weeks.
Testing earlier than 8 weeks post-injection is essentially useless — your levels will still be within the therapeutic range even if the protocol needs adjustment. The useful test is the one taken just before your next injection, which tells you whether the dosing interval is appropriate for maintaining levels within range.
Loading dose protocols (two injections 4-6 weeks apart, then maintenance at 10-14 week intervals) require especially careful timing. Do not test during the loading phase. Wait until you are 4-5 half-lives into the maintenance schedule — roughly 6-8 months after your first injection — before relying on results for clinical decisions.
Sustanon 250
Draw at: this is unreliable regardless of timing. Sustanon's multi-ester formulation produces erratic serum levels that depend heavily on injection site, depth, and individual esterase activity. The propionate component creates an early spike, the phenylpropionate and isocaproate components produce intermediate peaks, and the decanoate component lingers for weeks.
If you must use Sustanon and need blood work, the most consistent approach is to draw at the midpoint between injections — for a 2-week interval, draw at day 7. But expect variability between draws even with identical timing. If your results are bouncing unpredictably and your dose adjustments are not producing the expected changes, consider that Sustanon's pharmacokinetics, not your health, is the variable.
Practical recommendation: If you are on Sustanon and struggling with consistent blood work, switching to a single-ester formulation (enanthate or cypionate) will resolve most of the variability. In our experience, roughly 80% of patients who switch from Sustanon to a single ester report more predictable lab results and better symptom control.
Injection Frequency and Steady-State Dynamics
Your injection frequency changes not just your serum levels but also your draw strategy. The same ester produces different peak-to-trough ratios at different injection intervals, and you need to match your draw window to your specific protocol.
Weekly injections produce the largest peak-to-trough swings. Your draw window needs to be the most precise here because a difference of one day can change your result by 20-30%.
Twice-weekly (E3.5D) injections produce a flatter curve with smaller oscillations. The trough is easier to hit because the levels are more stable, but you still need to draw at the end of your injection interval — just before your next injection. For Monday morning / Thursday evening protocols, the best draw time is Thursday morning before your injection.
Every-other-day (EOD) injections, typically used with propionate, produce very stable levels with minimal oscillation. The draw window is wider, but the absolute levels are lower because less testosterone is released per injection. Draw at least 24 hours after your last injection, ideally just before your next one.
Steady state itself is worth understanding. It takes approximately 4-5 half-lives of consistent dosing to reach steady state. For enanthate (half-life ~5 days), that is about 20-25 days. For cypionate (half-life ~8 days), about 32-40 days. If you recently changed your dose, your results before steady state are not reliable for clinical decisions. Wait at least 4 weeks after a dose change before drawing, ideally 6 weeks for complete confidence.
Steady State Rule
The "Injection Morning" Rule
There is one universal rule that applies to every ester and every injection frequency: never draw on injection day. If you inject on Monday mornings, do not draw on Monday morning before or after your injection. The pre-injection draw on injection day still has residual levels from the previous dose that are not representative of your trough. The post-injection draw captures the beginning of the next release curve. Either way, the result is misleading.
Wait a minimum of 24 hours after your injection before drawing. For longer esters, wait 48 hours. This ensures that any residual from the previous injection has cleared and the new injection's release has stabilized enough to produce a reliable measurement.
The same logic applies to gel and cream formulations. Testosterone gels produce peak levels 2-4 hours after application, with a gradual decline over 24 hours. Apply your gel in the morning and draw the following morning — 24 hours post-application — for a consistent reading. Drawing on the same day as application captures the peak and will significantly overestimate your average 24-hour level.
The Injection Morning Trap
Clinical Implications: Why Timing Errors Lead to Wrong Decisions
A poorly timed blood draw has consequences that extend beyond an inaccurate lab result. Clinicians use testosterone levels to make decisions about dosing — and those decisions are only as good as the data they are based on.
Scenario 1: The dose reduction you did not need. You inject 120 mg of testosterone cypionate twice per week. You draw on day 2 (near peak) and your total testosterone comes back at 1,300 ng/dL. Your clinician, following guidelines that recommend a target of 800-1,000 ng/dL, reduces your dose to 80 mg twice per week. On the new dose, your true trough (day 5) is 320 ng/dL — well below the therapeutic threshold of 500 ng/dL. You spend the next 6-8 weeks feeling fatigued, low libido, and struggling in the gym. The original dose was fine; the timing of the draw was not.
Scenario 2: The unnecessary dose increase. You inject 100 mg of testosterone enanthate weekly. You draw on day 5 (trough) and your level is 520 ng/dL. Your clinician increases your dose to 140 mg weekly. On the new dose, your peak at day 2-3 reaches 1,400 ng/dL — supraphysiological for you. Your hematocrit rises, your HDL drops further, and your estradiol is now 65 pg/dL, requiring additional intervention. Your original trough of 520 ng/dL was within the therapeutic range and did not need adjustment. The problem was not the dose — it was that the clinician does not typically work with trough values and misinterpreted a 520 as "low."
Scenario 3: The inconsistency that looks like pathology. You alternate between drawing at day 3 (mid-peak, result 1,100 ng/dL) and day 6 (near trough, result 550 ng/dL). Your clinician sees two results that look dramatically different and assumes your levels are unstable. This triggers additional testing, sometimes includes SHBG, free testosterone, estradiol, LH/FSH, and even pituitary imaging to rule out a source of fluctuation. The actual source of fluctuation is your draw timing, not your physiology. Standardizing your draw window eliminates the apparent instability.
Consistency Over Precision
Beyond Total Testosterone: Free T, SHBG, and Estradiol Timing
Total testosterone is not the only marker affected by draw timing. Free testosterone is calculated from total T and SHBG — if total T is measured at the wrong time, the free T estimate follows. But SHBG itself is relatively stable and is not meaningfully affected by injection timing, so a single SHBG measurement at any point in your cycle gives a reliable baseline.
Estradiol follows a similar curve to total testosterone because it is produced by aromatization of the testosterone you inject. If you draw at peak total T, your estradiol will also be at its peak. For most patients this is not a problem because the E2:T ratio stays relatively constant — but if you are using an aromatase inhibitor and timing its administration around your injection schedule, draw consistently at the same point in your cycle to get comparable E2 results.
Hematocrit is worth a separate mention. TRT-induced erythrocytosis takes weeks to develop and weeks to resolve, so your hematocrit is not affected by the timing of your last injection. You can draw a hematocrit at any point in your injection cycle and get a reliable result. The same applies to lipid panels, liver enzymes, and kidney markers — only testosterone and its direct metabolites (estradiol, DHT) are sensitive to within-cycle timing.
Putting It All Together: Your Draw Protocol
Here is the simplified protocol. Identify your ester from the list above, match your injection frequency, and follow the draw window. Lock in that window for all future draws. If you change esters or injection frequency, reset your draw window accordingly.
- Propionate: Draw at 48 hours post-injection. Be precise — small timing variations produce meaningful differences.
- Enanthate: Draw at 84-96 hours (day 3.5-4). The midpoint of the injection interval produces a reliable result.
- Cypionate: Draw at 96-120 hours (day 4-5). The longer half-life provides a wider window, but earlier than day 4 risks a near-peak reading.
- Undecanoate: Draw just before your next injection. Do not test during the loading phase.
- Sustanon: Accept that results will vary. Consider switching to a single ester for reliable monitoring.
Always document your draw timing alongside your results. If your testosterone changes between labs and you want to know whether it is a real change or a timing artifact, the injection-to-draw interval is your first clue. Write down the date and time of your last injection before the draw, and bring it to your appointment. A three-second note prevents weeks of confusion.
If you are using Gel or Cream: apply in the morning, draw the following morning (minimum 24 hours post-application). Gel formulations have their own peak-to-trough dynamics that are different from injectables — the absorption curve depends on the application site, skin condition, and even the temperature of the room. Draw at the same relative time (24 hours post-application) every time for the most consistent results.
Final Protocol Summary
The difference between a well-timed TRT blood draw and a poorly timed one is not a few percentage points of accuracy. It is the difference between a protocol that works for you and one that your clinician keeps adjusting based on unreliable numbers. Your doctor can only make good decisions with good data — and good data starts with drawing at the right time.